Wang Hanlu, Dai Sen, Zhang Jianhui, Li Yi, Gan Yumian, Lu Tao, Zhu Yaobin, Wu Jiabin, Lin Ning, Tang Faqiang, Luo Jiewei
Shengli Clinical Medical College of Fujian Medical University Fuzhou 350001, China.
Fujian Provincial Hospital Fuzhou 350001, China.
Am J Transl Res. 2020 Dec 15;12(12):8123-8136. eCollection 2020.
Autosomal dominant polycystic kidney disease (ADPKD) is the common hereditary kidney disease, resulting from mutations in polycystic kidney disease 1 () and polycystic kidney disease 2 (). Clinical data and genetic features of six Chinese families including ADPKD patients were analyzed via Next generation sequencing (NGS), Sanger sequencing, and multiplex ligation-dependent probe amplification. In family A, the proband (II5) with polycystic kidney (PK), hypertension, left ventricular hypertrophy, and valvular heart disease exhibited a heterozygous nonsense mutation, c.5086C>T (p.Gln1696Ter), in (NM_001009944). In family B, the proband (II3) with PK, polycystic liver (PL), hypertension, hypertrophy of the left ventricle and septum, valvular heart disease, chronic kidney disease (CKD) stage 5, bilateral renal calculi, and right inguinal hernia exhibited a heterozygous missense mutation, c.6695T>C (p.Phe2232Ser), in . In family C, the proband (III1) with PK, PL, seminal vesicle cyst, hypertension, CKD stage 3, hypertrophy of the left ventricle and septum, and valvular heart disease harbored a heterozygous nonsense mutation, c.662T>G (p.Leu221Ter), in (NM_000297). In family D, the proband (III3) with PK, hypertension, and CKD stage 5 harbored a heterozygous missense mutation, c.8311G>A (p.Glu2771Lys), in . In family E, the proband (II1) with PK, PL, hypertension, and CKD stage 5 exhibited a heterozygous deletion mutation, exon15-22, in . In family F, the proband (II2) with PK, PL, CKD stage 3, hypertension, thickened interventricular septum, and valvular heart disease carried a heterozygous missense mutation, c.1649A>G (p.His550Arg), in . Thus, three novel mutation sites which are responsible for ADPKD were discovered in this study.
常染色体显性多囊肾病(ADPKD)是常见的遗传性肾病,由多囊肾病1(PKD1)和多囊肾病2(PKD2)的突变引起。通过下一代测序(NGS)、桑格测序和多重连接依赖探针扩增技术,对包括ADPKD患者在内的6个中国家庭的临床数据和遗传特征进行了分析。在A家族中,患有多囊肾(PK)、高血压、左心室肥厚和瓣膜性心脏病的先证者(II5)在PKD1(NM_001009944)中表现出杂合性无义突变,c.5086C>T(p.Gln1696Ter)。在B家族中,患有PK、多囊肝(PL)、高血压、左心室和室间隔肥厚、瓣膜性心脏病、慢性肾脏病(CKD)5期、双侧肾结石和右腹股沟疝的先证者(II3)在PKD1中表现出杂合性错义突变,c.6695T>C(p.Phe2232Ser)。在C家族中,患有PK、PL、精囊囊肿、高血压、CKD 3期、左心室和室间隔肥厚以及瓣膜性心脏病的先证者(III1)在PKD1(NM_000297)中存在杂合性无义突变,c.662T>G(p.Leu221Ter)。在D家族中,患有PK、高血压和CKD 5期的先证者(III3)在PKD1中存在杂合性错义突变,c.8311G>A(p.Glu2771Lys)。在E家族中,患有PK、PL、高血压和CKD 5期的先证者(II1)在PKD1中表现出杂合性缺失突变,外显子15 - 22。在F家族中,患有PK、PL、CKD 3期、高血压、室间隔增厚和瓣膜性心脏病的先证者(II2)在PKD1中携带杂合性错义突变,c.1649A>G(p.His550Arg)。因此,本研究发现了3个导致ADPKD的新突变位点。